Alex Pasteur is a Partner at F-Prime Capital Partners, a position held since October 2012. In addition to this role, Alex serves as a Non Executive Director for multiple companies including Oviva, ARTBIO, Tenpoint Therapeutics, Ltd., NodThera, Genomics, Peptone, and Pulmocide, as well as for Shift Bioscience. Alex also holds a position as a Board Observer at Castor. Academic qualifications include a PhD in Chemistry and a Master of Arts in Natural Sciences, both obtained from the University of Cambridge.
This person is not in the org chart
This person is not in any offices